Current guidelines for differentiated thyroid carcinoma (DTC) (1, 2) assign a crucial diagnostic importance to stimulated thyroglobulin (s-Tg) measurement 6–12 months after completion of primary therapy to predict a recurrence-free follow-up than in previous guideline versions. The gene discussed is TG; the disease is differentiated thyroid carcinoma.